Who invested in Tranzyme?
Tranzyme's investors include BDC Capital, H.I.G. Capital, Quaker Partners, Thomas, McNerney & Partners and Desjardins Venture Capital, and 2 more on record.
United States · Venture startup
2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$20Mraised across 2 rounds since 2005, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Tranzyme's investors include BDC Capital, H.I.G. Capital, Quaker Partners, Thomas, McNerney & Partners and Desjardins Venture Capital, and 2 more on record.
Tranzyme has raised $20M across 2 rounds since 2005. One round did not disclose an amount, so the total is a floor.
Tranzyme's most recent round was a Venture of $20M in Nov 2007.
Its most recent round, $20M in Nov 2007, is also its largest on record.
Tranzyme's first round on record, in May 2005, was backed by BDC Capital, Desjardins Venture Capital and H.I.G. Capital and 4 others.
Tranzyme's latest named round is a Venture, in Nov 2007.
Tranzyme is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.